Ratings eHealth, Inc.

Equities

EHTH

US28238P1093

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
4.53 ^USD	+2.49%		+0.89%	-48.05%

04-26	Adherium Seeks to Raise AU$8.4 Million Via Placement, Entitlement Offer; Shares Fall 24%	MT
04-18	EHealth Reaffirms 2024 Guidance	MT

Strengths

The stock, which is currently worth 2024 to 0.16 times its sales, is clearly overvalued in comparison with peers.
The company appears to be poorly valued given its net asset value.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Over the past four months, analysts' average price target has been revised downwards significantly.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Multiline Insurance & Brokers

	1st Jan change	Capi.	ESG Refinitiv
EHEALTH, INC.	-48.05%	131M	C-
ARTHUR J. GALLAGHER & CO.	+4.10%	51.16B	B-
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	+4.04%	25.66B	C+
BROWN & BROWN, INC.	+14.55%	23.24B	C
CAIXA SEGURIDADE PARTICIPAÇÕES S.A.	+26.59%	9.56B	-
RYAN SPECIALTY HOLDINGS, INC.	+13.76%	5.81B	-
STEADFAST GROUP LIMITED	-4.12%	4.02B	B
AUB GROUP LIMITED	+1.30%	1.99B	C+
BRP GROUP, INC.	+11.16%	1.76B	C-
GOOSEHEAD INSURANCE, INC	-26.78%	1.4B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes